Source comparison
TB-500 vs BPC-157 vs GHK-Cu: Recovery Peptide Comparison
TB-500 Actin upregulation, cell migration, angiogenesis Tendons, ligaments, chronic soft tissue 2x/week loading, 1x/week maintenance High. Drives new capillary formation Gold standard for tendon/ligament injuries where vascularization is the limiting factor BP
This comparison does not assign a generated winner or score.
- TB-500
- Actin upregulation, cell migration, angiogenesis
- Tendons, ligaments, chronic soft tissue
- 2x/week loading, 1x/week maintenance
- High. Drives new capillary formation
- Gold standard for tendon/ligament injuries where vascularization is the limiting factor
- BPC-157
- Nitric oxide modulation, VEGF activation, gut-brain-joint axis
- GI-related injuries, muscle tears, joint inflammation
- Daily subcutaneous
- Moderate. Improves existing vessel function
- Broader anti-inflammatory profile but less targeted for structural tissue repair
- GHK-Cu
- Copper peptide, collagen/elastin synthesis, metalloproteinase regulation
- Skin wounds, post-surgical scars, cosmetic repair
- Daily topical or subcutaneous
- Low. Primarily remodeling, not angiogenesis
- Excellent for surface-level tissue remodeling but insufficient for deep tendon/ligament injuries
- IGF-1 LR3
- Insulin-like growth factor receptor activation, satellite cell proliferation
- Muscle hypertrophy, post-atrophy recovery
- 3–5x/week
- Minimal direct vascular effect
- Promotes muscle growth but does not address inflammation or collagen organization
- Sermorelin
- Growth hormone secretagogue, systemic GH elevation
- System-wide recovery, sleep quality, indirect tissue support
- Daily before bed
- Indirect. Improves systemic recovery environment
- Supports overall recovery but lacks tissue-specific targeting for acute injuries
- TB-500's unique advantage is its dual action on inflammation and vascularization. It both reduces inflammatory cytokines and builds the blood supply needed to sustain long-term repair. BPC-157 offers faster subjective pain relief but doesn't drive angiogenesis to the same degree, making it less effective for injuries where blood flow is the primary bottleneck.